The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study

The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: عظیمه ایزدی , مهرانگیز ابراهیمی ممقانی

کلمات کلیدی: Insulin resistance, Major depressive disorder, Malondialdehyde, Metabolic syndrome, Obesity, Oxidative stress

نشریه: 13461 , 4 , 11 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مهرانگیز ابراهیمی ممقانی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات علوم تغذیه
کد مقاله 77637
عنوان فارسی مقاله The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study
عنوان لاتین مقاله The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: There is evidence for a bidirectional association between obesity and depression, and obesity is the main risk factor for metabolic syndrome (MetS). This study aimed to compare oxidative stress and MetS features between depressed and non-depressed obese women and study the association of depressive symptoms, oxidative stress, and components of MetS. Methods: In this case-control study conducted in Tabriz (East Azarbaijan, Iran), obese women (body mass index [BMI]: 30-40 kg/m2) with a primary diagnosis of major depressive disorder (MDD; based on diagnostic interview with a psychiatrist; n = 75) and their age-matched nondepressed controls (n = 150) were enrolled. Beck Depression Inventory-version II (BDI-II) was used to assess depressive symptoms in both groups. Anthropometric parameters, blood pressure, fasting blood sugar (FBS), lipid profile and malondialdehyde (MDA) were measured. Results: No significant differences in anthropometric parameters and blood pressure were observed between the two groups. However, FBS of the MDD group was significantly higher than the control (P < 0.05). FBS was significantly correlated with BDI-II scores (r = 0.158, P = 0.017). No significant difference in lipid profile was observed between the groups. Serum MDA level was significantly lower in the MDD group and was inversely associated with BDI-II scores (r = -0.328, P < 0.001). Overall, MDD was not significantly associated with MetS in our study (OR = 0.848, 95% CI: 0.484, 1.487; P = 0.566). Conclusion: Although we found a correlation between higher depressive symptoms and some adverse metabolic outcomes, our findings do not support a significant association between MDD and MetS.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
عظیمه ایزدیدوم
مهرانگیز ابراهیمی ممقانیسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
The association of depression with metabolic syndrome.pdf1400/10/06295724دانلود